Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
Source
← All Sources

Foley Health Care Law

11 stories

  1. Legal

    Foley & Lardner Warns Device Makers on U.S. Compliance Risk

    In a Foley & Lardner LLP client alert, the firm argues that medical device companies entering the U.S. market should prioritize corporate compliance programs given active DOJ and HHS-OIG enforcement under the False Claims Act, Anti-Kickback Statute, and Foreign Corrupt Practices Act. The firm cites settlements including ResMed ($37.5 million, 2020), Innovasis ($12 million, 2024), Aesculap Implant Systems ($38.5 million, 2025), and Diopsys ($14.25 million, 2025), covering kickbacks to providers, off-label promotion, and false claims to Medicare and Medicaid. The firm recommends building compliance programs around OIG's seven elements and focusing on provider financial relationships, promotional and billing practices, distributor oversight, and transfer-of-value reporting.

    Foley · 3 days ago
  2. Legal

    Foley & Lardner Previews 2026 State Attorney General Election Risks

    In a special report, Foley & Lardner examines the 2026 state attorney general election cycle, noting that 33 AG races (30 states plus D.C., Guam, and the Northern Mariana Islands) will occur in November 2026, guaranteeing at least 11 new attorneys general by January 2027. The firm highlights that AG offices wield broad authority over consumer protection, antitrust, Medicaid fraud enforcement, environmental law, and charitable oversight, making leadership transitions significant for businesses across health care, technology, energy, and financial services. The report flags enforcement trends to watch, including multistate investigations, AI and data privacy scrutiny, and federal-state litigation, and offers compliance-readiness steps for companies ahead of the transition period. No specific race outcomes or new enforcement actions are reported; the piece is forward-looking guidance for business risk planning.

    Foley · 43 days ago
  3. Legal

    Warren, Wyden Introduce Bill to Ban Corporate Practice of Medicine Nationwide

    In its September 25 publication, Foley & Lardner reports that Senators Elizabeth Warren, Ron Wyden, and Jeff Merkley, along with three House members, introduced the Stop Corporate Takeovers of Physicians Act on September 16, 2026. The legislation would impose federal restrictions on corporate practice of medicine (CPOM), targeting private equity ownership structures and management services organization (MSO) arrangements commonly used in physician practice acquisitions. If enacted, the bill would affect how private equity firms and corporate entities structure their investments in physician practices, potentially requiring restructuring of existing MSO-based transactions that rely on management agreements to circumvent state CPOM restrictions. The legislation matters for Medicaid managed care organizations and providers because many MCO networks include physician groups owned through MSO structures, and federal CPOM restrictions could disrupt network composition, provider contracting models, and care delivery arrangements.

    Foley · 57 days ago
  4. Legal

    DOJ Revises Justice Manual to Strengthen False Claims Act Enforcement

    On September 18, 2026, the Department of Justice announced revisions to the Justice Manual strengthening False Claims Act enforcement. The changes affect how DOJ pursues FCA cases, including potential modifications to dismissal policies and limitations on relying on sub-regulatory guidance as the basis for FCA liability. Healthcare providers, including those serving Medicaid beneficiaries, face increased enforcement scrutiny. The revisions took effect immediately upon announcement.

    Foley · 60 days ago
  5. Legal

    DOL Warns Plans to Maintain Mental Health Parity Compliance Despite Non-Enforcement Posture

    The Department of Labor, HHS, and Treasury have adopted a non-enforcement posture for the final Mental Health Parity and Addiction Equity Act regulations published in fall 2024, but are warning employers and health plans that compliance remains expected. The guidance signals that while the agencies are not actively enforcing the 2024 final rule, they continue to monitor mental health parity compliance more broadly. This creates compliance uncertainty for Medicaid managed care plans and other health plans that must determine which parity requirements remain enforceable and how to demonstrate compliance without clear enforcement standards.

    Foley · 66 days ago
  6. Industry

    Foley Partner to Speak on Medicare and Medicaid Administrative Enforcement Trends

    Foley & Lardner partner Judy Waltz will present on Medicare and Medicaid administrative enforcement trends at the California Society for Healthcare Attorneys Fall Seminar. The session will address emerging enforcement patterns affecting healthcare providers and plans. No specific date or enforcement details are provided in the announcement.

    Foley · 71 days ago
  7. Legal

    DOJ Expands Fraud Enforcement Division with Added Staff and Data Resources

    The Department of Justice's National Fraud Enforcement Division is expanding its fraud enforcement operations targeting recipients of federal funds, including Medicaid providers and managed care organizations. DOJ is increasing investigative staff and deploying enhanced data analytics capabilities to detect fraud, with particular focus on schemes involving foreign nationals and government program integrity. The expanded enforcement posture takes effect immediately, reflecting DOJ's renewed prioritization of fraud prevention and recovery across federal healthcare programs. Medicaid providers, health plans, and state agencies should anticipate heightened scrutiny of billing practices, program compliance, and financial arrangements.

    Foley · 78 days ago
  8. Legal

    Court Dismisses False Claims Act Case on Medicare Advantage Marketing Practices

    A federal court dismissed a sealed False Claims Act case alleging Medicare Advantage marketing violations. The relator attempted to characterize patient acquisition and outreach activities as fraudulent claims for payment. The dismissal demonstrates judicial skepticism toward FCA theories targeting marketing conduct rather than false billing. The outcome matters for Medicare Advantage plans facing similar qui tam allegations linking enrollment practices to improper payment.

    Foley · 135 days ago
  9. Legal

    DOJ Intensifies Medicaid Fraud Enforcement Under Trump Administration

    The Trump Administration has significantly increased enforcement focus on waste, fraud, and abuse in Medicaid over the past six months, with the Department of Justice prioritizing False Claims Act cases against Medicaid providers and managed care organizations. This heightened scrutiny follows longstanding federal efforts to recover improper Medicaid payments but marks a notable acceleration in enforcement activity. The increased DOJ attention raises compliance and financial risk for Medicaid managed care plans, particularly around billing accuracy, utilization management, and encounter data reporting. Plans should expect more qui tam investigations and potential enforcement actions.

    Foley +7 more · 152 days ago
  10. Legal

    California Doctor Convicted in $45 Million Medicare Botox Fraud Scheme

    A federal jury in the Central District of California convicted Dr. Violetta Mailyan for orchestrating a $45 million Medicare fraud scheme involving fraudulent Botox injection claims. The conviction reflects DOJ's increasing use of data analytics to identify and prosecute billing anomalies and fraud patterns in federal health programs. The case demonstrates heightened federal enforcement targeting suspicious billing practices, particularly for high-cost procedure codes and injectable medications. Medicaid managed care organizations face similar fraud detection scrutiny and should strengthen their claims review protocols and provider oversight mechanisms.

    Foley · 165 days ago
  11. Legal

    DOJ Orders Fast-Track Review of Sealed Medicaid False Claims Act Cases

    The Department of Justice announced May 27, 2026, that civil attorneys must prioritize and expedite sealed qui tam cases alleging fraud against Medicaid and other federally funded, state-administered benefit programs. Assistant Attorney General Brett Shumate directed DOJ Civil Division and U.S. Attorney's Office lawyers to fast-track these investigations. The directive applies immediately to pending sealed cases. This signals heightened federal enforcement scrutiny of Medicaid fraud allegations and may accelerate the timeline from complaint filing to government intervention decisions or unsealing.

    Foley · 165 days ago

Get the daily briefing.